A similar study by the same group (2016) showed that apigenin (0–100 μM) inhibited CSCs (CD44+ PCa stem cells) and PC-3 cell survival, with a significant increase of p21 and p27, both of which are anti-apoptotic proteins. This evidence concerns the gene CD44 and posterior cortical atrophy.